Changing Outcomes, Saving Lives
0.5 CE Credit Hour / Veterinarians & Veterinary Technicians
Overview:
“How lucky to be in Veterinary Medicine! You get to play with puppies and kittens all day.” We have all heard that and we all know that is not even close to being true.
Even if we do have puppy or kitten patients; they are not always healthy. Parvo is a disease that destroys wellbeing in all – the puppy, the owner, and the veterinary team. Fighting to save the life of a sick puppy has not only physical demands, but also significant mental strain and emotional drain. Adding cases like this to an already overwhelmed and overworked staff can deplete morale, stamina, and resources.
How can we change the outcome for the better when a puppy is diagnosed with parvo? Elanco’s Canine Parvovirus Monoclonal Antibody (CPMA) is the first and only USDA conditionally approved treatment that specifically targets canine parvo. Helping save puppies’ lives and to improve the lives of the people who care for them, this single dose of compassion goes a long way in energizing the veterinary team to care for their patients, clients, and themselves.
Learning Objectives:
- The impact of Meaning in the work. What happens when we have it and when we lose it.
- The effect of empathetic exhaustion and burnout on the veterinary team.
- How Compassion can serve as the antidote to the negative effects of veterinary medicine.
- How CPMA can improve the lives of the veterinary professionals caring for parvo puppies.
Heidi Hulon, DVM, CCCP, CPPP, MHFA
Moderator:
This program is pending approval for 0.5 hour(s) of continuing education credit in jurisdictions that recognize RACE® approval.
This activity is sponsored by Elanco.
